Upstream Bio, Inc. (UPB)

Upstream Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	2.37	2.38	1.21
Revenue Growth (YoY)	-0.42%	96.37%	-
Gross Profit	2.37	2.38	1.21
Selling, General & Admin	17.17	10.7	6.46
Research & Development	62.97	31.8	18.66
Operating Expenses	80.13	42.49	25.12
Operating Income	-77.76	-40.11	-23.91
Interest & Investment Income	12.12	4.17	0.21
Other Non Operating Income (Expenses)	2.84	15.41	-0.16
Pretax Income	-62.81	-20.54	-23.87
Net Income	-62.81	-20.54	-23.87
Preferred Dividends & Other Adjustments	13.59	17.72	-
Net Income to Common	-76.4	-38.26	-23.87
Shares Outstanding (Basic)	14	3	3
Shares Outstanding (Diluted)	14	3	3
Shares Change (YoY)	363.22%	5.49%	-
EPS (Basic)	-5.58	-12.95	-8.52
EPS (Diluted)	-5.58	-12.95	-8.52
Free Cash Flow	-59.68	-38.07	-19.1
Free Cash Flow Per Share	-4.36	-12.89	-6.82
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-3281.18%	-1685.46%	-1972.69%
Profit Margin	-3223.42%	-1607.35%	-1969.31%
Free Cash Flow Margin	-2518.27%	-1599.58%	-1576.15%
EBITDA	-77.68	-40.05	-23.9
D&A For EBITDA	0.09	0.06	0.01
EBIT	-77.76	-40.11	-23.91

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q